PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gam...
Continue Reading →
news

Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

Immatics and Genmab to Combine Proprietary Technologies to Create Transformative Bispecific Therapies against Novel, Proprietary Tumor Targets Immatics to Receiv...
Continue Reading →
news

PharmaKrysto announces licensing agreement with Rutgers University for new treatment for people with cystinuria

PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today that it has completed an exclusive global licensing deal with Rutgers University,...
Continue Reading →
news

ANTABIO Completes € 12.5M Series A

New investors Omnes, BNP Paribas Développement and Sham Innovation Santé invest an additional €5.2M on top of the €7.3M first closing announced in October 2017 Antab...
Continue Reading →
news

Xbrane and STADA enter into a co-development agreement for Xlucane

Xbrane Biopharma AB ("Xbrane") and STADA Arzneimittel AG ("STADA") have entered into a co-development agreement for Xlucane, a Lucentis® (ranibizumab) biosimilar. ...
Continue Reading →
news

Qiagen to expand biomarker research in UK

The new health innovation campus will support the continued growth of businesses which are driving the future shape of medicine and health care. Qiagen has announce...
Continue Reading →
news

Merck inks deal with China’s Xian Janssen for type 2 diabetes drug

China has more than 114 million people living with diabetes, the largest number of any country in the world Global drug giant, Merck signed an agreement with Chi...
Continue Reading →
news

Global Bioinformatics network PRASM to List on CoinBene

PRASM is a decentralized AI-based bioinformatics network and its protocol stores and utilizes biometrics on a blockchain database. According to PRASM, the biometr...
Continue Reading →
news

GT Healthcare invests $26.6M in Potrero Medical

The funding will support further commercialization efforts of the company's flagship product, the Accuryn Monitoring System. Potrero Medical, Inc., a predictive h...
Continue Reading →
news

International Conference on Molecular Biology and Stem Cells

The world's largest Molecular Biology Conference and Stem Cells gathering for the Research Community, Join the Genetics Conference at Copenhagen, Denmark on Aug13-15,...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC